How severe is CVE-2023-31497?

CVE-2023-31497 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2023-31497 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (40th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-31497?

CVE-2023-31497 affects Seqrite End Point Security. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-31497?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2023-31497 published?

CVE-2023-31497 was published on 2023-05-11 and last updated on 2026-06-17.

CVE-2023-31497

CVE-2023-31497 is a high-severity vulnerability in Seqrite End Point Security with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: High (CVSS 3.x base score 7.8)
EPSS exploit prediction: 1% (40th percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Seqrite End Point Security
Published: 2023-05-11
Last modified: 2026-06-17

Description

Incorrect access control in Quick Heal Technologies Limited Seqrite Endpoint Security (EPS) all versions prior to v8.0 allows attackers to escalate privileges to root via supplying a crafted binary to the target system.

Frequently asked questions

What is CVE-2023-31497?: Incorrect access control in Quick Heal Technologies Limited Seqrite Endpoint Security (EPS) all versions prior to v8.0 allows attackers to escalate privileges to root via supplying a crafted binary to the target system.
How severe is CVE-2023-31497?: CVE-2023-31497 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-31497 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (40th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-31497?: CVE-2023-31497 affects Seqrite End Point Security. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-31497?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-31497 published?: CVE-2023-31497 was published on 2023-05-11 and last updated on 2026-06-17.

References

https://github.com/0xInfection/EPScalate

Affected products (1)

cpe:2.3:a:seqrite:end_point_security:*:*:*:*:*:*:*:*

More vulnerabilities in Seqrite End Point Security

CVE-2018-17775 — High (CVSS 7.8): Seqrite End Point Security v7.4 has "Everyone: (F)" permission for %PROGRAMFILES%\Seqrite\Seqrite, which allows local…

All CVEs affecting Seqrite End Point Security →